| Application | Comment | Organism |
|---|---|---|
| medicine | alpha-L-iduronidase is used in enzyme replacement therapy approved for mucopolysaccharidosis type I treatment | Homo sapiens |
| Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
|---|---|---|---|
| 85000 | - |
x * 85000, SDS-PAGE | Homo sapiens |
| 480000 | - |
gel filtration and native PAGE | Homo sapiens |
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| additional information | Homo sapiens | the enzyme hydrolyzes terminal iduronic acid residues on glycosaminoglycans | ? | - |
? |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
| Posttranslational Modification | Comment | Organism |
|---|---|---|
| glycoprotein | N-glycosylation, deglycoslyation b peptide N-glycosidase F from Flavobacterium meningosepticum and neuraminidase from Clostridium perfringens. The N-glycan pools consists of oligomannosidic glycans (mainly Man7, Man8, Man9 as well as Man9 + Glc), complex type glycans with up to three antennae. Sialylation as well as fucosylation are observed on almost all complex type glycans | Homo sapiens |
| phosphoprotein | phosphorylations on S59 and S482, phosphatase treatment | Homo sapiens |
| side-chain modification | histidine methylation at H572 | Homo sapiens |
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| brain | - |
Homo sapiens | - |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| 4-methylumbelliferyl-alpha-L-iduronide + H2O | - |
Homo sapiens | 4-methylumbelliferol + alpha-L-iduronic acid | - |
? | |
| additional information | the enzyme hydrolyzes terminal iduronic acid residues on glycosaminoglycans | Homo sapiens | ? | - |
? |
| Subunits | Comment | Organism |
|---|---|---|
| oligomer | x * 85000, SDS-PAGE | Homo sapiens |
| Synonyms | Comment | Organism |
|---|---|---|
| alpha-L-iduronidase | - |
Homo sapiens |
| IDUA | - |
Homo sapiens |
| Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
|---|---|---|---|
| 21 | - |
assay at | Homo sapiens |
| pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
|---|---|---|---|
| 3.4 | - |
assay at | Homo sapiens |
| General Information | Comment | Organism |
|---|---|---|
| malfunction | deficiency of the enzyme leads to progressive accumulation of glycosaminoglycans, dermatan and heparan sulfate, in all organs and tissues, mucopolysccharidosis I is a lysosomal storage disorder that results from deficiency in the lysosomal enzyme alpha-L-iduronidase. Infusions of intravenous enzyme improves hepatosplenomegaly, pulmonary function, ambulation, jointmobility, cardiac function, and cognitive and neuroradiological progress | Homo sapiens |